Market Overview

Morning Market Losers

Related THLD
Threshold Pharma Says Phase 3 Trial of TH-302 in Patients with Advanced Soft Tissue Sarcoma Will Continue as Planned
Events for the Week of Sept. 8-12
Related TRGT
Stocks Hitting 52-Week Lows
Morning Market Losers

Threshold Pharmaceuticals (NASDAQ: THLD) fell 28.10% to $6.27 at 9:55 am. Threshold Pharmaceuticals announced data from Phase 2b clinical trial of TH-302 in combination with Gemcitabine.

Targacept (NASDAQ: TRGT) shares dipped 11.34% to $4.30. Targacept reported top-line results from a Phase 2 trial of TC-5619 in adults with inattentive-predominant attention deficit/hyperactivity disorder.

Tandy Brands Accessories (NASDAQ: TBAC) shares lost 10.74% to $1.33. Tandy Brands Accessories' trailing-twelve-month ROE is -12.63%.

MGC Diagnostics (NASDAQ: MGCD) dropped 10.51% to $5.28. MGC Diagnostics' trailing-twelve-month operating margin is -1.93%.

Posted-In: News Movers & Shakers Intraday Update Markets

 

Related Articles (TBAC + MGCD)

Around the Web, We're Loving...

Get Benzinga's Newsletters